219 related articles for article (PubMed ID: 8027327)
21. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L
J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
[TBL] [Abstract][Full Text] [Related]
22. Activity of fluconazole against Candida albicans isolates from HIV+ patients in a digestive candidosis turkey model.
Reynes J; Mallie M; Ravisse P; Bastide JM
J Med Vet Mycol; 1992; 30(5):363-7. PubMed ID: 1469537
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.
Martínez M; López-Ribot JL; Kirkpatrick WR; Bachmann SP; Perea S; Ruesga MT; Patterson TF
J Antimicrob Chemother; 2002 Mar; 49(3):515-24. PubMed ID: 11864952
[TBL] [Abstract][Full Text] [Related]
24. Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
Cartledge JD; Midgley J; Gazzard BG
AIDS; 1997 Dec; 11(15):1839-44. PubMed ID: 9412702
[TBL] [Abstract][Full Text] [Related]
25. Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients.
Revankar SG; Kirkpatrick WR; McAtee RK; Dib OP; Fothergill AW; Redding SW; Rinaldi MG; Patterson TF
J Infect Dis; 1996 Oct; 174(4):821-7. PubMed ID: 8843222
[TBL] [Abstract][Full Text] [Related]
26. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
27. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis.
Pfaller MA; Rhine-Chalberg J; Redding SW; Smith J; Farinacci G; Fothergill AW; Rinaldi MG
J Clin Microbiol; 1994 Jan; 32(1):59-64. PubMed ID: 7907345
[TBL] [Abstract][Full Text] [Related]
28. Fluconazole-resistant oral candidosis in a repeatedly treated female AIDS patient.
Thomas-Greber E; Korting HC; Bogner J; Goebel FD
Mycoses; 1994; 37(1-2):35-8. PubMed ID: 7935590
[TBL] [Abstract][Full Text] [Related]
29. Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection.
Redding SW; Pfaller MA; Messer SA; Smith JA; Prows J; Bradley LL; Fothergill AW; Rinaldi MG
J Clin Microbiol; 1997 Jul; 35(7):1761-5. PubMed ID: 9196188
[TBL] [Abstract][Full Text] [Related]
30. Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients.
Martins MD; Lozano-Chiu M; Rex JH
Clin Infect Dis; 1998 Nov; 27(5):1291-4. PubMed ID: 9827284
[TBL] [Abstract][Full Text] [Related]
31. Persistent oral candidosis by non-albicans Candida strains including Candida glabrata in a human immunodeficiency virus-infected patient observed over a period of 6 years.
Hoegl L; Thoma-Greber E; Röcken M; Korting HC
Mycoses; 1998; 41(7-8):335-8. PubMed ID: 9861840
[TBL] [Abstract][Full Text] [Related]
32. Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole.
Bart-Delabesse E; Boiron P; Carlotti A; Dupont B
J Clin Microbiol; 1993 Nov; 31(11):2933-7. PubMed ID: 7903316
[TBL] [Abstract][Full Text] [Related]
33. Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits.
Lasker BA; Elie CM; Lott TJ; Espinel-Ingroff A; Gallagher L; Kuykendall RJ; Kellum ME; Pruitt WR; Warnock DW; Rimland D; McNeil MM; Reiss E
Med Mycol; 2001 Aug; 39(4):341-52. PubMed ID: 11556764
[TBL] [Abstract][Full Text] [Related]
34. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.
Johnson EM; Warnock DW; Luker J; Porter SR; Scully C
J Antimicrob Chemother; 1995 Jan; 35(1):103-14. PubMed ID: 7768758
[TBL] [Abstract][Full Text] [Related]
35. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F
Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
[TBL] [Abstract][Full Text] [Related]
36. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.
Pelletier R; Peter J; Antin C; Gonzalez C; Wood L; Walsh TJ
J Clin Microbiol; 2000 Apr; 38(4):1563-8. PubMed ID: 10747144
[TBL] [Abstract][Full Text] [Related]
37. [Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS].
Diz P; Ocampo A; Miralles C; Otero I; Iglesias I; Martínez C
Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):36-9. PubMed ID: 8461371
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance.
Sangeorzan JA; Bradley SF; He X; Zarins LT; Ridenour GL; Tiballi RN; Kauffman CA
Am J Med; 1994 Oct; 97(4):339-46. PubMed ID: 7942935
[TBL] [Abstract][Full Text] [Related]
39. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
Chryssanthou E; Torssander J; Petrini B
Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
[TBL] [Abstract][Full Text] [Related]
40. Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients.
Vuffray A; Durussel C; Boerlin P; Boerlin-Petzold F; Bille J; Glauser MP; Chave JP
AIDS; 1994 May; 8(5):708-9. PubMed ID: 8060555
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
